Valuation: Alcon Inc.

Capitalization 31.25B 26.89B 24.59B 23.46B 43.01B 2,999B 43.72B 295B 114B 1,423B 117B 115B 4,959B P/E ratio 2026 *
29.7x
P/E ratio 2027 * 23.1x
Enterprise value 33.85B 29.13B 26.63B 25.41B 46.59B 3,248B 47.36B 320B 124B 1,542B 127B 124B 5,372B EV / Sales 2026 *
3.04x
EV / Sales 2027 * 2.77x
Free-Float
97.36%
Yield 2026 *
0.54%
Yield 2027 * 0.63%
1 day+1.63%
1 week+2.54%
Current month-13.40%
1 month-20.35%
3 months-17.34%
6 months-18.28%
Current year-20.32%
1 week 47.8
Extreme 47.8
51.12
1 month 47.8
Extreme 47.8
64.08
Current year 47.8
Extreme 47.8
68.34
1 year 47.8
Extreme 47.8
74.92
3 years 47.8
Extreme 47.8
87
5 years 47.8
Extreme 47.8
87
10 years 38.62
Extreme 38.625
87
Manager TitleAgeSince
Chief Executive Officer 60 30/06/2018
Director of Finance/CFO 58 07/04/2019
Chief Tech/Sci/R&D Officer - 31/12/2024
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 30/06/2018
Director/Board Member 63 31/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
+1.63%+2.54%-31.04%-29.36% 31.25B
+0.03%+1.08%-31.58%-6.23% 92.62B
-1.28%-0.65%-26.81%-38.76% 11.63B
-1.08%-4.09% - - 8.49B
-2.52%-4.62%+80.33%+728.89% 2.76B
-1.63%-6.28%-11.28%-56.12% 1.75B
+1.32%+2.50%-26.23%-17.91% 1.11B
-4.37%-0.85% - - 776M
+1.73%+4.06%-16.22%-16.45% 728M
+2.83%-3.05%+36.60%-44.13% 729M
Average -0.33%-1.12%-3.28%+64.99% 15.18B
Weighted average by Cap. +0.14%+0.71%-28.19%-0.70%

Financials

2026 *2027 *
Net sales 11.13B 9.58B 8.76B 8.35B 15.31B 1,068B 15.57B 105B 40.65B 507B 41.76B 40.87B 1,766B 11.83B 10.18B 9.3B 8.88B 16.27B 1,135B 16.54B 112B 43.19B 539B 44.38B 43.43B 1,876B
Net income 1.09B 934M 854M 815M 1.49B 104B 1.52B 10.24B 3.96B 49.42B 4.07B 3.98B 172B 1.38B 1.19B 1.09B 1.04B 1.9B 132B 1.93B 13.02B 5.04B 62.84B 5.18B 5.07B 219B
Net Debt 2.6B 2.24B 2.04B 1.95B 3.58B 249B 3.64B 24.53B 9.49B 118B 9.75B 9.54B 412B 1.54B 1.33B 1.21B 1.16B 2.12B 148B 2.16B 14.57B 5.64B 70.31B 5.79B 5.67B 245B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
15/05/26 50.42 CHF +1.63% 1,917,236
13/05/26 49.61 CHF -1.10% 1,926,008
12/05/26 50.16 CHF +2.89% 2,779,115
11/05/26 48.75 CHF -0.85% 3,975,689
08/05/26 49.17 CHF -2.29% 2,362,644
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
64.08USD
Average target price
96.45USD
Spread / Average Target
+50.50%

Quarterly revenue - Rate of surprise